Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
Abstract Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent….
Abstract Cannabidiol (CBD), a major non-psychotropic component of cannabis, is receiving growing attention as a potential anticancer agent….
Abstract Introduction: Glioblastoma (GBM) is the most common invasive brain tumor composed of diverse cell types with poor prognosis….
Abstract Glioma is the most common primary malignant brain tumor with poor survival and limited therapeutic options. The…
Abstract Radiotherapy combined with chemotherapy is the major treatment modality for human glioblastoma multiforme (GBM). GBMs eventually relapse…
Abstract Glioblastoma is the most common primary brain tumor in adults. While the introduction of temozolomide chemotherapy has…
Abstract Glioblastoma multiforme (GBM) is the most common and aggressive form of primary malignant brain tumor in adults,…
Abstract Despite advances in glioblastoma (GBM) therapy, prognosis of the disease remains poor with a low survival rate….
Abstract Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. The challenging problem in cancer…
Abstract Evidence suggests that the nonpsychotropic cannabis-derived compound, cannabidiol (CBD), has antineoplastic activity in multiple types of cancers,…
Abstract Glioblastoma (GBM) is the most common form of primary adult brain tumors. A majority of GBMs grow…